Sfoglia per Autore
The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo.
2003-01-01 RELAIX F ;POLIMENI M ;ROCANCOURT D ;PONZETTO C ;SCHÄFER BW ;BUCKINGHAM M
RNAI AS A TOOL TO SUPPRESS TPR-MET MEDIATED TUMORIGENESIS
2003-01-01 P. ACCORNERO; TAULLI R; MANGANO T; CREPALDI T; PONZETTO C
Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development
2002-01-01 A. IERACI; P.E. FORNI; C. PONZETTO
Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity.
2002-01-01 MIRANDA C ;ZANOTTI G ;PAGLIARDINI S ;PONZETTO C ;PIEROTTI MA ;GRECO A
Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis.
2002-01-01 MULLER M.; MOROTTI A.; C. PONZETTO
Preferential binding of Grb2 or phosphatidylinositol 3-kinase to the met receptor has opposite effects on HGF-induced myoblast proliferation.
2002-01-01 Y. LESHEM; I. GITELMAN; C. PONZETTO; O. HALEVY
K252a inhibits the oncogenic properties of Met, the HGF receptor.
2002-01-01 A. MOROTTI; S. MILA; P. ACCORNERO; E. TAGLIABUE; C. PONZETTO
Coupling Met to specific pathways results in distinct developmental outcomes.
2001-01-01 MAINA F;PANTÉ G;HELMBACHER F;ANDRES R;PORTHIN A;DAVIES AM;PONZETTO C;KLEIN R
Growth factor supplemented matrigel improves ectopic Growth factor supplemented matrigel improves ectopic skeletal muscle formation-a cell therapy approach.
2001-01-01 BARBERO A ;BENELLI R ;MINGHELLI S ;TOSETTI F ;DORCARATTO A ;PONZETTO C ;WERNIG A ;CULLEN MJ ;ALBINI A ;NOONAN DM BARBERO A.; BENELLI R.; MINGHELLI S.; TOSETTI F.; DORCARATTO A.; C. PONZETTO; WERNIG A.; CULLEN M.J.; ALBINI A.; NOONAN D.M.
Activation of NF-kB is essential for HGF-mediated tubuligenesis, but not for protection from apoptosis
2001-01-01 Muller M; Morotti A; Ponzetto C
Met signaling mutants as tools for developmental studies.
2000-01-01 PONZETTO C; PANTÉ G; PRUNOTTO' C; IERACI A; MAINA F
K252a inhibits the oncogenic properties of Met, the HGF receptor
2000-01-01 Alessandro Morotti; Carola Ponzetto
K252a inhibits the oncogenic proprerties of Met, the HGF receptor
2000-01-01 A.Morotti; A. Bosia; C. Ponzetto
Two mutations affecting conserved residues in the Met receptor operate via different mechanisms
2000-01-01 MARITANO D; ACCORNERO P; BONIFACI N; PONZETTO C
Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration.
1999-01-01 DE ANGELIS L.; BERGHELLA L.; COLETTA M.; LATTANZI L.; ZANCHI M.; CUSELLA DE ANGELIS MG.; C. PONZETTO; COSSU G.
Hepatocyte growth factor/scatter factor-MET signaling in neural crest-derived melanocyte development.
1999-01-01 KOS L ;ARONZON A ;TAKAYAMA H ;MAINA F ;PONZETTO C ;MERLINO G ;PAVAN W
Concomitant activation of pathways downstream of Grb2 and PI 3-kinase is required for MET-mediated metastasis.
1999-01-01 A. BARDELLI; M.L. BASILE; E. AUDERO; S. GIORDANO; S. WENNSTROM; S. MENARD; P.M. COMOGLIO; C. PONZETTO
Physiological function of receptor-SH2 interactions.
1998-01-01 C. PONZETTO
P230 BCR/ABL protein may be associated with an acute leukaemia phenotype.
1998-01-01 HASKOVEC C.; C. PONZETTO; POLAK J.; MARITANO D.; ZEMANOVA Z.; SERRA A.; MICHALOVA K.; KLAMOVA H.; CERMAK J.; SAGLIO G.
A point mutation in the MET oncogene abrogates metastasis without affecting transformation.
1997-01-01 GIORDANO S; BARDELLI A; ZHEN Z; MENARD S; PONZETTO C; COMOGLIO PM
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile